Occurrence of antibiotic resistant enterococci in clinical specimens from a pediatric hospital

Polish Journal of Microbiology

Volumn 54, Issue 1, 2005, Pages 77-80

  Rudy, Maria ^a   Zientara, Maria ^a   Bek, Tomasz ^a   Martirosian, Gayane ^a,b  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Enterococci; Glycopeptides; HLAR; Synercid

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; DALFOPRISTIN PLUS QUINUPRISTIN; GENTAMICIN; STREPTOMYCIN; TEICOPLANIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; ENTEROCOCCUS; ENTEROCOCCUS CASSELIFLAVUS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ENTEROCOCCUS GALLINARUM; HUMAN; INFECTION CONTROL; PEDIATRIC HOSPITAL; URINARY TRACT INFECTION;

ADULT; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, BACTERIAL; ENTEROCOCCUS; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HOSPITALS; HUMANS; INFANT; INFANT, NEWBORN; MICROBIAL SENSITIVITY TESTS; POLAND;

ENTEROCOCCUS; ENTEROCOCCUS CASSELIFLAVUS; ENTEROCOCCUS DURANS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ENTEROCOCCUS GALLINARUM;

EID: 20744447338     PISSN: 17331331     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Aleksandrowicz I. 1999. Antibiotic resistant strains of Enterococcus sp. isolated from urinary tract (in Polish). Med. Dośw. Mikrobiol. 51: 233-238
2. Baier R J., J.A. Bocchini Jr. and E.G. Brown. 1998. Selective use of vancomycin to prevent coagulase-negative staphylococcal nosocomial bacteremia in high risk very low birth weight infants. Pediatr. Infect. Dis. J. 17: 179-83
3. Braak van den N., A. Ott, A. van Belkum, J.A. Kluytmans, et al. 2002. Prevalance and determinants of fecal colonization with vancomycin-resistant Enterococcus in hospitalized patients in the Netherlands. Infect. Control. Hosp. Epidemiol. 21: 520-524.
4. Bronk M., A. Samet and A. Hellmann. 1997. Isolation and epidemiological study of vancomycin-resistant Enterococcus faecium from patients of a haematological unit in Poland. J. Hosp. Infect. 2: 71-4
5. Dzierżanowska D., A. Pawinska, W. Kaminska and J. Patzer. 2004. Drug resistant microorganisms in hospital infections (in Polish). Post. Mikrobiol. 43: 81-105
6. Dzierżanowska D. 1999. Etiological agents of hospital infections - Streptococci, p. 70-71. In: D. Dzierżanowska, J. Jeliaszewicz (eds), Hospital infections α-medica Press. Bielsko-Biała.
7. Dzierżanowska D. 2000. Mechanisms of bacterial resistance to antibiotics and chemiotherapeutics. p. 18. In: D. Dzierżanowska (ed.), Practical antibiotic therapy (in Polish), α-medica Press, Bielsko-Biała.
8. Facklam R.R., D.F. Sahm and L.M. Teixeira. 1999. Enterococcus In: P.R. Murray (ed.), Manual of Clinical Microbiology. 7: 297.
9. Hayes J.R., A.C. McIntosh, S. Qaiyumi, J.A. Jonson et al. 2001. High-frequency recovery of quinupristin-dalfopristin-resistant Enterococcus faecium isolates from the poultry production environent. J. Clin. Microbiol. 39: 2298-229
10. Hryniewicz W., A. Sulikowska, K. Szczypa, M. Krzyszton-Rusian et al. 2003. Reccommendations for antibiotic/chemiotherapeutic susceptibility testing of bacteria (in Polish). Mikrobiol. Med. 2: 15-41
11. Hryniewicz K., K. Szczypa, A. Sulikowska, K. Jankowski et al. 2001. Antibiotic susceptibility of bacterial strains isolated from urinary tract infections in Poland. J. Antimicrob. Chemother. 47: 773-778
12. Hryniewicz W., T. Zareba and M. Kawalec. 1998. Susceptibility patterns of Enterococcus spp. isolated in Poland during 1996. Int. J. Antimicrob. Agent. 10: 303-307
13. Malik R.K., M.A. Montecalvo, M.R. Reale, K. Li et al. 1999. Epidemiology and control of vancomycin-resistant enterococci in a regional neonatal intensive care unit. Pediatr. Infect. Dis. J. 18: 352-356
14. Moellering R.C., P.K. Linden, J. Reinhardt, E.A. Blumberg and F. Bompart. 1999. Talbet for the Synercid Emergency - Use Study Group.: The efficacy and safety of quinupristin/dalfopristin for the treatment of infections caused by vancomycin-resistant Enterococcus faecium. J. Antimicrob. Chemother. 44: 251-261
15. Neely M. and P. Toltzis. 2001. Infection control in pediatric hospitals. Cun. Opin. Infect. Dis. 14: 449-453
16. Ozorowski T., L. Konopka, M. Zaleska and G. Polynyczko. 2003. Enterococci resistant to vancomycin (in Polish). Zakażenia. 1: 34-38
17. Perencevich E.N., D.N. Fisman, M. Lipsitch, A.D. Harris et al. 2004. Projected benefits of active surveillance for Vancomycin-Resistant Enterococci in intensive care units. Clin. Infect. Dis. 38: 1108-1115
18. Randhava V.S., L. Kapoor, V. Singh and G. Mehta. 2004. Aminoglycoside resistance in enterococci isolated from paediatric septicaemia in a tertiary care hospital in north India. Indian J. Med. Res. 119: 77-79
19. Scheuten M.A., A. Voss, J.A.A. Hoogkammp-Korstanje and European VRE Study Group. 1999. Antimicrobial susceptibility patterns of enterococci causing infections in Europe. Antimicrob. Agents. Chemother. 43: 2542-2546
20. Silverman J., L.A. Thal, M.B. Perri, G. Bostic et al. 1998. Epidemiologic evaluation of antimicrobial resistance in community-acquired enterococci. J. Clin. Microbiol. 36: 1-7